TY - GEN
T1 - Haier Biomedical’s Value Added Statement for the Internet of Things
AU - Yue, Tao
AU - Wang, Shaofei
AU - Zhu, Liang
AU - Feng, Weizhong
PY - 2024/11/1
Y1 - 2024/11/1
N2 - In June 2018, Haier Group, the world's fourth-largest white goods manufacturer, intensified its shift towards an Internet of Things (IoT) model and ecological sustainability. Within the field of life sciences and medical advancements, Haier Biomedical, a subsidiary of Haier Group, unveiled the pioneering 'U-Blood IoT Blood Safety Management Solution.' In April 2021, Haier Biomedical successfully tested an enhanced iteration of U-Blood, named the 'Smart Blood City Network,' enabling centralized blood resource management within city hospitals. How should the financial statements account for the value of this 'network' within the IoT framework? And how could Haier Group effectively evaluate the realization of network value in its assessment of Haier Biomedical's performance?
AB - In June 2018, Haier Group, the world's fourth-largest white goods manufacturer, intensified its shift towards an Internet of Things (IoT) model and ecological sustainability. Within the field of life sciences and medical advancements, Haier Biomedical, a subsidiary of Haier Group, unveiled the pioneering 'U-Blood IoT Blood Safety Management Solution.' In April 2021, Haier Biomedical successfully tested an enhanced iteration of U-Blood, named the 'Smart Blood City Network,' enabling centralized blood resource management within city hospitals. How should the financial statements account for the value of this 'network' within the IoT framework? And how could Haier Group effectively evaluate the realization of network value in its assessment of Haier Biomedical's performance?
UR - https://casecent.re/p/201907
M3 - Teaching case
ER -